Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Bacteriophages, or phages, are viruses that infect bacteria. They were discovered around a century ago and have been used ever since for therapeutic purposes, particularly in former Soviet Union countries. Their use in Western countries was abandoned after the discovery and broad use of penicillin. The rising problem of antimicrobial resistance has revived interest in bacteriophage therapy. The aim of this article is to provide a comprehensive review of all aspects of natural phage therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Pros and cons of phage therapy
Loc-Carrillo, C., & Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.2.14590 · Cited by 1,020
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
A century of the phage: past, present and future
Salmond, G. P. C., & Fineran, P. C. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3564 · Cited by 823
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases
Citorik, R. J., Mimee, M., & Lu, T. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.3011 · Cited by 808
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Bacteriophages: Biology and Applications
Silver, S., & Baylor, M. (2006) · Microbe Magazine · doi:10.1128/microbe.1.151.1 · Cited by 570
Sarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., Bourdin, G., McCallin, S., Ngom-Bru, C., Neville, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.023 · Cited by 533
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Why is big Pharma getting out of antibacterial drug discovery?
Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria
Yosef, I., Manor, M., Kiro, R., & Qimron, U. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500107112 · Cited by 483
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009) · Journal of Wound Care · doi:10.12968/jowc.2009.18.6.42801 · Cited by 468
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Phage Choice, Isolation, and Preparation for Phage Therapy
Gill, J., & Hyman, P. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725311 · Cited by 441
Genetically Engineered Phages: a Review of Advances over the Last Decade
Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., & Lu, T. K. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00069-15 · Cited by 427
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Clinical Aspects of Phage Therapy
Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóż, P., Kłak, M., Wojtasik, E., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00003-7 · Cited by 373
Nelson, D. C., Schmelcher, M., Rodriguez-Rubio, L., Klumpp, J., Pritchard, D. G., Dong, S., & Donovan, D. M. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00007-4 · Cited by 372
Cisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, Z. (2017) · Current Microbiology · doi:10.1007/s00284-016-1166-x · Cited by 318
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
Experimental Phage Therapy against Staphylococcus aureus in Mice
Capparelli, R., Parlato, M., Borriello, G., Salvatore, P., & Iannelli, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01513-06 · Cited by 300
Abedon, S., & Thomas-Abedon, C. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725410 · Cited by 284
Quality and Safety Requirements for Sustainable Phage Therapy Products
Pirnay, J.-P., Blasdel, B. G., Bretaudeau, L., Buckling, A., Chanishvili, N., Clark, J. R., Corte-Real, S., Debarbieux, L., Dublanchet, A., De Vos, D., et al. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1617-7 · Cited by 276
Phage therapy experience at the Eliava Institute
Kutateladze, M., & Adamia, R. (2008) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2008.06.023 · Cited by 258
Jennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Viertel, T. M., Ritter, K., & Horz, H.-P. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku173 · Cited by 243
A century of phage research: Bacteriophages and the shaping of modern biology
Keen, E. C. (2015) · BioEssays · doi:10.1002/bies.201400152 · Cited by 242
Bacteriophage treatment of intransigent diabetic toe ulcers: a case series
Fish, R., Kutter, E., Wheat, G., Blasdel, B., Kutateladze, M., & Kuhl, S. (2016) · Journal of Wound Care · doi:10.12968/jowc.2016.25.7.s27 · Cited by 222
Phage Neutralization by Sera of Patients Receiving Phage Therapy
Łusiak-Szelachowska, M., Żaczek, M., Weber-Dąbrowska, B., Międzybrodzki, R., Kłak, M., Fortuna, W., Letkiewicz, S., Rogóż, P., Szufnarowski, K., Jończyk-Matysiak, E., et al. (2014) · Viral Immunology · doi:10.1089/vim.2013.0128 · Cited by 218
Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes
Edgar, R., Friedman, N., Molshanski-Mor, S., & Qimron, U. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05741-11 · Cited by 217
Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., Uchiyama, J., Sakurai, S., Matsuzaki, S., Imai, S., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00635-06 · Cited by 206
service, P. (2007) · Research in Microbiology · doi:10.1016/j.resmic.2007.07.005 · Cited by 201
Regeimbal, J. M., Jacobs, A. C., Corey, B. W., Henry, M. S., Thompson, M. G., Pavlicek, R. L., Quinones, J., Hannah, R. M., Ghebremedhin, M., Crane, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02877-15 · Cited by 187
Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model
Wills, Q. F., Kerrigan, C., & Soothill, J. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1220-1221.2005 · Cited by 180
Bacteriophage Procurement for Therapeutic Purposes
Weber-Dąbrowska, B., Jończyk-Matysiak, E., Żaczek, M., Łobocka, M., Łusiak-Szelachowska, M., & Górski, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01177 · Cited by 178
Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials
Vandenheuvel, D., Lavigne, R., & Brüssow, H. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-054915 · Cited by 176
Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy
Oliveira, H., São-José, C., & Azeredo, J. (2018) · Viruses · doi:10.3390/v10060292 · Cited by 170
Hua, Y., Luo, T., Yang, Y., Dong, D., Wang, R., Wang, Y., Xu, M., Guo, X., Hu, F., & He, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02659 · Cited by 166
Hung, C., Kuo, C.-F., Wang, C.-H., Wu, C.-M., & Tsao, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01123-10 · Cited by 165
On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy
Mattila, S., Ruotsalainen, P., & Jalasvuori, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01271 · Cited by 165
Safety and efficacy of phage therapy via the intravenous route
Speck, P., & Smithyman, A. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv242 · Cited by 160
Cao, F., Wang, X., Wang, L., Li, Z., Che, J., Wang, L., Li, X., Cao, Z., Zhang, J., Jin, L., et al. (2015) · BioMed Research International · doi:10.1155/2015/752930 · Cited by 159
Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model
Nath, G., Kishor, C., Mishra, R., Saraf, S., Kumar, M., & Srivastav, A. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.178615 · Cited by 151
Kumari, S., Harjai, K., & Chhibber, S. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.018580-0 · Cited by 149
Żaczek, M., Łusiak-Szelachowska, M., Jończyk-Matysiak, E., Weber-Dąbrowska, B., Międzybrodzki, R., Owczarek, B., Kopciuch, A., Fortuna, W., Rogóż, P., & Górski, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01681 · Cited by 127
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L., Gong, J., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.309 · Cited by 121
Phage therapy: awakening a sleeping giant
Roach, D. R., & Debarbieux, L. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170002 · Cited by 116
Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
Fukuda, K., Ishida, W., Uchiyama, J., Rashel, M., Kato, S.-I., Morita, T., Muraoka, A., Sumi, T., Matsuzaki, S., Daibata, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047742 · Cited by 112
What are the limitations on the wider therapeutic use of phage?
Henein, A. (2013) · Bacteriophage · doi:10.4161/bact.24872 · Cited by 104
Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung
Pabary, R., Singh, C., Morales, S., Bush, A., Alshafi, K., Bilton, D., Alton, E. W. F. W., Smithyman, A., & Davies, J. C. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01426-15 · Cited by 100
Cheng, M., Liang, J., Zhang, Y., Hu, L., Gong, P., Cai, R., Zhang, L., Zhang, H., Ge, J., Ji, Y., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00837 · Cited by 98
Kusradze, I., Karumidze, N., Rigvava, S., Dvalidze, T., Katsitadze, M., Amiranashvili, I., & Goderdzishvili, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01590 · Cited by 94
Effects of bacteriophages on free radical production and phagocytic functions
Przerwa, A., Zimecki, M., Świtała-Jeleń, K., Dąbrowska, K., Krawczyk, E., Łuczak, M., Weber‐Dąbrowska, B., Syper, D., Międzybrodzki, R., & Górski, A. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0011-4 · Cited by 92
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Tao, D., Ding, L., Reed, E., et al. (2006) · PubMed · Cited by 81
Bacteriophages: biology and history
Sharp, R. (2001) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.434 · Cited by 79
Dufour, N., Debarbieux, L., Fromentin, M., & Ricard, J.-D. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000968 · Cited by 75
The Effect of Bacteriophage Preparations on Intracellular Killing of Bacteria by Phagocytes
Jończyk-Matysiak, E., Łusiak-Szelachowska, M., Kłak, M., Bubak, B., Międzybrodzki, R., Weber-Dąbrowska, B., Żaczek, M., Fortuna, W., Rogóż, P., Letkiewicz, S., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/482863 · Cited by 65
Bacteriophage Clinical Use as Antibacterial “Drugs”: Utility and Precedent
Abedon, S. T. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0003-2016 · Cited by 61
Rossitto, M., Fiscarelli, E. V., & Rosati, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00775 · Cited by 59
Preliminary survey of local bacteriophages with lytic activity against multi‐drug resistant bacteria
Latz, S., Wahida, A., Arif, A., Häfner, H., Hoß, M., Ritter, K., & Horz, H. (2016) · Journal of Basic Microbiology · doi:10.1002/jobm.201600108 · Cited by 46
Oduor, J. M. O., Onkoba, N., Maloba, F., Arodi, W. O., & Nyachieo, A. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7931 · Cited by 35
Cited by
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0437-z · Cited by 1,410
Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
Principi, N., Silvestri, E., & Esposito, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00513 · Cited by 454
Pepi, M., & Focardi, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115723 · Cited by 297
Zarei-Baygi, A., & Smith, A. L. (2021) · Bioresource Technology · doi:10.1016/j.biortech.2020.124181 · Cited by 261
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Metadata
- Authors
- Kakasis, A., & Panitsa, G.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 16-21
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2889989499
- Cited by
- 261
- References
- 67
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.